Pinnacle Medicines | $89,000,000 | (Mar 27, 2026)
CurrentClient | $1,250,000 | (Mar 27, 2026)
Mirage | $75,000,000 | (Mar 27, 2026)
DRUID AI
United Kingdom
- London
- 15/09/2023
- Series B
- $30,000,000
We are DRUID AI, and we provide the best end-to-end platform for AI-driven conversational business applications.
DRUID AI-powered virtual assistants enable fast, personalized, and hyper-automated interactions designed to deliver next-level employee productivity and a superior customer experience. Our conversational AI solutions speak each organization's language through seamless integrations with any enterprise system and Robotic Process Automation (RPA) technologies.
With 130+ partners and 100+ clients worldwide, DRUID AI actively builds on its vision to provide employees with an intelligent virtual assistant that helps people work easier and faster.
✳️ Discover the power that conversational AI can have on your business – https://druidai.com
🤝 If you want to join our team, check out our Jobs section on LinkedIn – https://druidai.com/jobs. We're always looking for talented people who wish to embark on our journey and contribute to how AI and automation are helping people work better.
- Industry Software Development
- Website https://www.druidai.com/
- LinkedIn https://www.linkedin.com/company/druidai/about/
Scalvy | $13,900,000 | (Mar 27, 2026)
SIGMAS | $1,000,000 | (Mar 27, 2026)
VITL | $7,500,000 | (Mar 27, 2026)
Payy | $6,000,000 | (Mar 27, 2026)
Conntour | $7,000,000 | (Mar 27, 2026)
KilgourMD | Undisclosed Amount | (Mar 27, 2026)
Terrestrial | $50,000,000 | (Mar 27, 2026)
Krane | $9,000,000 | (Mar 26, 2026)
Zalos (YC F25) | $3,600,000 | (Mar 26, 2026)